Duopharma Biotech Bhd
KLSE:DPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Duopharma Biotech Bhd
Cash & Cash Equivalents
Duopharma Biotech Bhd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Cash & Cash Equivalents
290.9m
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Cash & Cash Equivalents
15.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
16%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Cash & Cash Equivalents
227.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Cash & Cash Equivalents
45.9m
|
CAGR 3-Years
42%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Cash & Cash Equivalents
148.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Cash & Cash Equivalents
12.8m
|
CAGR 3-Years
33%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-2%
|
|
Duopharma Biotech Bhd
Glance View
Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.
See Also
What is Duopharma Biotech Bhd's Cash & Cash Equivalents?
Cash & Cash Equivalents
290.9m
MYR
Based on the financial report for Dec 31, 2025, Duopharma Biotech Bhd's Cash & Cash Equivalents amounts to 290.9m MYR.
What is Duopharma Biotech Bhd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
7%
Over the last year, the Cash & Cash Equivalents growth was 10%. The average annual Cash & Cash Equivalents growth rates for Duopharma Biotech Bhd have been 23% over the past three years , 13% over the past five years , and 7% over the past ten years .
